{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:44:51Z","timestamp":1781347491134,"version":"3.54.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH256"],"award-info":[{"award-number":["ZR2020QH256"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Tamoxifen is an endocrine therapy for breast cancer that works by competing with estradiol for estrogen receptors, but continued use of tamoxifen by patients can lead to resistance and metastasis. Studies have shown that 4-hydroxytamoxifen (4-OH-TAM), the active product of tamoxifen, promotes the malignant biological behavior of breast cancer cells, but the mechanism is not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the effects of 4-OH-TAM on breast cancer cell stemness, paclitaxel (PTX) resistance and metastasis. Molecular mechanism studies were used to investigate the pro-cancer effects of 4-OH-TAM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Treatment with low-dose 4-OH-TAM increased the resistance of ER-positive (MCF-7 and T47D cells) and triple-negative (4T1 and MDA-MB-231 cells) breast cancer cells to PTX. In vitro and in vivo experiments showed that 4-OH-TAM enhanced stemness in T47D and 4T1 cells by upregulating the stem cell markers CD44 and CD133. Mechanistically, 4-OH-TAM enhanced breast cancer cell stemness by upregulating estrogen-related receptor alpha (ERR\u03b1) protein expression via neuropilin-1 (NRP-1). Notably, inhibition of the NRP-1\/ERR\u03b1 signaling pathway reversed 4-OH-TAM-induced PTX resistance and tumor metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>4-hydroxytamoxifen enhances stemness through the NRP\/ERR\u03b1 pathway to enhance breast cancer cell PTX resistance and metastasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag007","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:25:27Z","timestamp":1768911927000},"source":"Crossref","is-referenced-by-count":1,"title":["4-hydroxytamoxifen enhances stemness through the neuropilin-1\/estrogen-related receptor alpha pathway to enhance breast cancer cell paclitaxel resistance and metastasis"],"prefix":"10.1093","volume":"78","author":[{"given":"Yanni","family":"Lv","sequence":"first","affiliation":[{"name":"Yantai Yuhuangding Hospital , 20 Yudong Road, Yantai, Shandong Province 264099 , PR","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglong","family":"Yu","sequence":"additional","affiliation":[{"name":"Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Pharmaceutical Science , 39 Science and Technology Avenue, Yantai, Shandong Province 264000 , PR","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Pharmaceutical Science , 39 Science and Technology Avenue, Yantai, Shandong Province 264000 , PR","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9050-872X","authenticated-orcid":false,"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"Yantai Yuhuangding Hospital , 20 Yudong Road, Yantai, Shandong Province 264099 , PR","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026021112482286900_ref1","doi-asserted-by":"publisher","first-page":"115441","DOI":"10.1016\/j.bcp.2023.115441","article-title":"Cancer stem cells: recent insights and therapies","volume":"209","author":"Zhou","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"2026021112482286900_ref2","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.smim.2020.101386","article-title":"Breast cancer stem cell antigens as targets for immunotherapy","volume":"47","author":"Quaglino","year":"2020","journal-title":"Semin Immunol"},{"key":"2026021112482286900_ref3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-030-35805-1_3","article-title":"Disseminated tumor cells and dormancy in breast cancer progression","volume":"1220","author":"Banys-Paluchowski","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"2026021112482286900_ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061897","article-title":"DNA repair and therapeutic strategies in cancer stem cells","volume":"15","author":"Gillespie","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026021112482286900_ref5","doi-asserted-by":"publisher","first-page":"115887","DOI":"10.1016\/j.taap.2022.115887","article-title":"Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil","volume":"437","author":"Nandi","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026021112482286900_ref6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/aje\/kww178","article-title":"Cytochrome P-450 2D6 (CYP2D6) genotype and breast cancer recurrence in tamoxifen-treated patients: evaluating the importance of loss of heterozygosity","volume":"185","author":"Ahern","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2026021112482286900_ref7","doi-asserted-by":"publisher","first-page":"e17248","DOI":"10.15252\/emmm.202217248","article-title":"Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERalpha(+) breast cancer","volume":"15","author":"Poulard","year":"2023","journal-title":"EMBO Mol Med"},{"key":"2026021112482286900_ref8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1200\/JCO.19.00126","article-title":"Adding ovarian suppression to tamoxifen for premenopausal breast cancer: a randomized phase III trial","volume":"38","author":"Kim","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026021112482286900_ref9","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.tranon.2022.101386","article-title":"Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells","volume":"19","author":"Calhoun","year":"2022","journal-title":"Transl Oncol"},{"key":"2026021112482286900_ref10","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1073\/pnas.151244398","article-title":"4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma","volume":"98","author":"Coward","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021112482286900_ref11","doi-asserted-by":"publisher","first-page":"563165","DOI":"10.3389\/fendo.2020.563165","article-title":"Continuous exposure of breast cancer cells to tamoxifen upregulates GPER-1 and increases cell proliferation","volume":"11","author":"Molina","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021112482286900_ref12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tox.2013.04.012","article-title":"4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells","volume":"309","author":"Li","year":"2013","journal-title":"Toxicology"},{"key":"2026021112482286900_ref13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/cr.2018.15","article-title":"Tamoxifen enhances stemness and promotes metastasis of ERalpha36(+) breast cancer by upregulating ALDH1A1 in cancer cells","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res"},{"key":"2026021112482286900_ref14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10020-021-00270-x","article-title":"Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis","volume":"27","author":"Tang","year":"2021","journal-title":"Mol Med"},{"key":"2026021112482286900_ref15","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1007\/s00018-020-03549-0","article-title":"Regulation of the expression of the estrogen related receptors (ERRs)","volume":"77","author":"Crevet","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"2026021112482286900_ref16","doi-asserted-by":"publisher","first-page":"102439","DOI":"10.1016\/j.coph.2024.102439","article-title":"Estrogen related receptor alpha: potential modulator of age-related macular degeneration","volume":"75","author":"Somers","year":"2024","journal-title":"Curr Opin Pharmacol"},{"key":"2026021112482286900_ref17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/1878-0261.13013","article-title":"The ERRalpha-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERRalpha overexpression correlates with poor prognosis in patients with basal-like breast cancer","volume":"16","author":"Danza","year":"2022","journal-title":"Mol Oncol"},{"key":"2026021112482286900_ref18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.canlet.2021.01.007","article-title":"FBXL10 promotes ERRalpha protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRalpha","volume":"502","author":"Yang","year":"2021","journal-title":"Cancer Lett"},{"key":"2026021112482286900_ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081819","article-title":"Cholesterol and mevalonate: two metabolites involved in breast cancer progression and drug resistance through the ERRalpha pathway","volume":"9","author":"Brindisi","year":"2020","journal-title":"Cells"},{"key":"2026021112482286900_ref20","doi-asserted-by":"publisher","first-page":"116110","DOI":"10.1016\/j.bcp.2024.116110","article-title":"Corynoxine triggers cell death via activating PP2A and regulating AKT-mTOR\/GSK3beta axes in NSCLC","volume":"222","author":"Hou","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"2026021112482286900_ref21","doi-asserted-by":"publisher","first-page":"114177","DOI":"10.1016\/j.bcp.2020.114177","article-title":"Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance spheroids formation via Src and TGF-beta signaling in breast cancer cells","volume":"180","author":"Galarza","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2026021112482286900_ref22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1248\/bpb.b22-00530","article-title":"Tamoxifen regulates epithelial-mesenchymal transition in endometrial cancer via the CANP10\/NRP1 signaling pathway","volume":"45","author":"Lv","year":"2022","journal-title":"Biol Pharm Bull"},{"key":"2026021112482286900_ref23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13058-024-01802-z","article-title":"TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via beta1-integrin\/FAK-TAZ-mTOR signaling axis by binding to MYH9","volume":"26","author":"Hu","year":"2024","journal-title":"Breast Cancer Res"},{"key":"2026021112482286900_ref24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canlet.2021.04.028","article-title":"GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling","volume":"514","author":"Li","year":"2021","journal-title":"Cancer Lett"},{"key":"2026021112482286900_ref25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13058-022-01502-6","article-title":"KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin\/c-Myc signaling pathway","volume":"24","author":"Yin","year":"2022","journal-title":"Breast Cancer Res"},{"key":"2026021112482286900_ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095058","article-title":"Tumour stem cells in breast cancer","volume":"23","author":"Ibragimova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026021112482286900_ref27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00280-024-04660-w","article-title":"Vitamin D suppresses CD133+\/CD44 + cancer stem cell stemness by inhibiting NF-kappaB signaling and reducing NLRP3 expression in triple-negative breast cancer","volume":"94","author":"Zheng","year":"2024","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026021112482286900_ref28","doi-asserted-by":"publisher","first-page":"8887","DOI":"10.2147\/OTT.S265372","article-title":"Estrogen-related receptor alpha (ERRalpha) and G protein-coupled Estrogen receptor (GPER) synergistically indicate poor prognosis in patients with triple-negative breast cancer","volume":"13","author":"Ye","year":"2020","journal-title":"Onco Targets Ther"},{"key":"2026021112482286900_ref29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41388-018-0579-3","article-title":"ERRalpha promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors","volume":"38","author":"Vargas","year":"2019","journal-title":"Oncogene"},{"key":"2026021112482286900_ref30","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1007\/s12015-023-10605-2","article-title":"Estrogen-related receptor alpha (ERRalpha) promotes cancer stem cell-like characteristics in breast cancer","volume":"19","author":"Muduli","year":"2023","journal-title":"Stem Cell Rev Rep"},{"key":"2026021112482286900_ref31","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1038\/ncomms12156","article-title":"ERRalpha mediates metabolic adaptations driving lapatinib resistance in breast cancer","volume":"7","author":"Deblois","year":"2016","journal-title":"Nat Commun"},{"key":"2026021112482286900_ref32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1158\/0008-5472.CAN-14-0652","article-title":"Reprogramming of the ERRalpha and ERalpha target gene landscape triggers tamoxifen resistance in breast cancer","volume":"75","author":"Thewes","year":"2015","journal-title":"Cancer Res"},{"key":"2026021112482286900_ref33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/onc.2017.399","article-title":"Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation","volume":"37","author":"Shi","year":"2018","journal-title":"Oncogene"},{"key":"2026021112482286900_ref34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-023-05696-1","article-title":"NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026021112482286900_ref35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.humpath.2018.06.030","article-title":"Neuropilin-1 (NRP-1) upregulated by IL-6\/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms","volume":"81","author":"Yang","year":"2018","journal-title":"Hum Pathol"},{"key":"2026021112482286900_ref36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3892\/ijo.2019.4938","article-title":"Neuropilin 1 modulates TGF-beta1-induced epithelial-mesenchymal transition in non-small cell lung cancer","volume":"56","author":"Ding","year":"2020","journal-title":"Int J Oncol"},{"key":"2026021112482286900_ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097792","article-title":"Neuropilin-1 knockout and rescue confirms its role to promote metastasis in MDA-MB-231 breast cancer cells","volume":"24","author":"Al-Zeheimi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026021112482286900_ref38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12885-024-12070-7","article-title":"Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer","volume":"24","author":"Maenpaa","year":"2024","journal-title":"BMC Cancer"},{"key":"2026021112482286900_ref39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12885-018-4446-y","article-title":"Neuropilin-1 promotes the oncogenic Tenascin-C\/integrin beta3 pathway and modulates chemoresistance in breast cancer cells","volume":"18","author":"Naik","year":"2018","journal-title":"BMC Cancer"},{"key":"2026021112482286900_ref40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13058-022-01501-7","article-title":"Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS\/MAPK pathway activation","volume":"24","author":"Tang","year":"2022","journal-title":"Breast Cancer Res"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/2\/rgag007\/66852328\/rgag007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/2\/rgag007\/66852328\/rgag007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:48:31Z","timestamp":1770832111000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag007\/8472819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag007","relation":{},"ISSN":["2042-7158"],"issn-type":[{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]},"article-number":"rgag007"}}